Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1053525


South Africa Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015


Description: South Africa Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South Africa cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices \in the South Africa

Scope

- The report provides cardiovascular devices market information broken down into detailed categories and segments in Soth Africa.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the cardiovascular devices market in South Africa.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Pacemakers
3.2.1.1 Single Chamber Pacemakers
3.2.1.2 Dual Chamber Pacemakers
3.2.2 Implantable Cardioverter Defibrillator (ICD)
3.2.2.1 Single Chamber Implantable Cardioverter Defibrillator
3.2.2.2 Dual Chamber Implantable Cardioverter Defibrillator
3.2.3 Cardiovascular Pacing and ICD Leads
3.2.4 Cardiac Resynchronization Therapy
3.2.4.1 Cardiac Resynchronisation Therapy - Pacemaker
3.2.4.2 Cardiac Resynchronisation Therapy - Defibrillator
3.3 Cardiovascular monitoring and diagnostic devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Holter Monitoring Systems
3.3.4 Event Monitoring Systems
3.4 Cardiovascular prosthetic device
3.4.1 Prosthetic heart valves
3.4.1.1 Mechanical heart valves
3.4.1.2 Tissue heart valve
3.4.2 Cardiac Valve Repair
3.4.3 Cardiac assist devices (Ventricular Assist Device (VAD))
3.4.3.1 Total Artificial Heart (TAH)
3.4.3.2 Intra Aortic Balloon Pump (IABP)
3.4.3.3 Intra Aortic Balloon Pump Catheters
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Systems
3.5.2 Perfusion Systems
3.5.3 Cardiac Ablation Devices
3.5.4 Cardiopulmonary Bypass Equipment
3.5.5 Perfusion Disposables
3.5.5.1 Oxygenators
3.5.5.2 Custom Packs
3.6 Electrophysiology
3.6.1 Electrophysiology diagnostic catheter
3.6.2 Electrophysiology ablation catheter
3.6.3 Electrophysiology lab systems
3.7 Interventional cardiology
3.7.1 Coronary Stents
3.7.1.1 Bare Metal Stents
3.7.1.2 Drug Eluting Coronary Stents
3.7.2 Cardiac Catheters
3.7.2.1 Guiding Catheters
3.7.2.2 Angiography catheters
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
3.7.3.1 Rapid Exchange PTCA Balloon Catheters
3.7.3.2 Over the Wire PTCA Balloon Catheters
3.7.3.3 Fixed Wire (FW) PTCA Balloon Catheters
3.7.4 Coronary Guidewire
3.7.5 Arteriotomy Closure Devices
3.8 Peripheral vascular devices
3.8.1 Peripheral Vascular Stents
3.8.2 Inferior Vena Cava Filter
3.8.3 PTA Balloon
3.8.4 Aortic Stent Graft
3.8.5 Embolic Protection Device
3.8.6 Synthetic Surgical Grafts
3.8.7 Peripheral Guidewire
4 Healthcare Sector Review
4.1 Proposed Health System in South Africa
5 Regulation System
5.1 Medical Equipment Regulation System
5.2 Regulation of Electromagnetic Medical Devices
5.3 Future Outlook
6 Pricing and Reimbursement
6.1 Reimbursement
6.2 Pricing
7 Distribution Structure
8 Cardiovascular Devices In South Africa
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, South Africa, Overall Revenue ($ mn), 2000-2015
8.3 Cardiovascular Devices, South Africa, Category Volume (Units), 2000-2015
8.4 Cardiovascular Devices, South Africa, Company Share (2007-2008)
9 Cardiac Rhythm Management In South Africa
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
9.1.3 Pacemaker Overall Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2015)
9.2.3 Pacemaker Overall Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, South Africa, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices In South Africa
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, South Africa, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices In South Africa
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
11.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices Overall Volume (2000-2015)
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, South Africa, Company Share (2007-2008)
12 Cardiovascular Surgery In South Africa
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Overall Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Overall Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, South Africa, Company Share (2007-2008)
13 Electrophysiology In South Africa
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Distribution Share (2007-2008)
13.5 Electrophysiology, South Africa, Company Share (2007-2008)
14 Interventional Cardiology In South Africa
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Overall Revenue (2000-2015)
14.1.2 Coronary Stent Overall Revenue (2000-2015)
14.1.3 PTCA Balloon Overall Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Overall Volume (2000-2015)
14.2.2 Coronary Stent Overall Volume (2000-2015)
14.2.3 PTCA Balloon Overall Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, South Africa, Company Share (2007-2008)
15 Peripheral Vascular Devices In South Africa
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, South Africa, Company Share (2007-2008)
16 Overview of Key Companies in South Africa Cardiovascular Devices Market
16.1 Boston Scientific Corporation
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.2.1 Manufacturing
16.1.2.2 Product Development
16.1.2.3 Sales and Marketing
16.1.3 Boston Scientific Corporation Pipeline Products
16.1.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type
16.1.3.2 Boston Scientific Corporation Pipeline Products by Development Stage
16.1.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area
16.1.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials
16.1.3.5 Boston Scientific Corporation Pipeline Products by News Summary
16.2 Medtronic, Inc.
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.2.1 Manufacturing
16.2.2.2 Product Development
16.2.2.3 Sales and Marketing
16.2.3 Medtronic, Inc. Pipeline Products
16.2.3.1 Medtronic, Inc. Pipeline Products by Equipment Type
16.2.3.2 Medtronic, Inc. Pipeline Products by Development Stage
16.2.3.3 Medtronic, Inc. Pipeline Products by Therapy Area
16.2.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials
16.2.3.5 Medtronic, Inc. Pipeline Products by News Summary
16.3 Cordis Corporation
16.3.1 Company Overview
16.3.2 Cordis Corporation Pipeline Products
16.3.2.1 Cordis Corporation Pipeline Products by Equipment Type
16.3.2.2 Cordis Corporation Pipeline Products by Development Stage
16.3.2.3 Cordis Corporation Pipeline Products by Therapy Area
16.3.2.4 Cordis Corporation Pipeline Products by Clinical Trials
16.3.2.5 Cordis Corporation Pipeline Products by News Summary
16.4 Abbott Laboratories
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.2.1 Manufacturing
16.4.2.2 Product Development
16.4.2.3 Sales and Marketing
16.5 St. Jude Medical Inc.
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.2.1 Manufacturing
16.5.2.2 Product Development
16.5.2.3 Sales and Marketing
16.5.3 St. Jude Medical Inc. Pipeline Products
16.5.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type
16.5.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage
16.5.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area
16.5.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials
16.5.3.5 St. Jude Medical Inc. Pipeline Products by News Summary
16.6 BIOTRONIK GmbH & Co. KG
16.6.1 Company Overview
16.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
16.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage
16.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area
16.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials
16.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary
16.7 Sorin S.p.A.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.2.1 Manufacturing
16.7.2.2 Product Development
16.7.2.3 Sales and Marketing
16.7.3 Sorin Group Pipeline Products
16.7.3.1 Sorin Group Pipeline Products by Equipment Type
16.7.3.2 Sorin Group Pipeline Products by Development Stage
16.7.3.3 Sorin Group Pipeline Products by Therapy Area
16.7.3.4 Sorin Group Pipeline Products by Clinical Trials
16.7.3.5 Sorin Group Pipeline Products by News Summary
16.8 GE Healthcare
16.8.1 Company Overview
16.9 Philips Healthcare
16.9.1 Company Overview
16.9.2 Value Chain Analysis
16.9.2.1 Manufacturing
16.9.2.2 Product Development
16.9.2.3 Sales and Marketing
16.9.3 Philips Medical Systems Pipeline Products
16.9.3.1 Philips Medical Systems Pipeline Products by Equipment Type
16.9.3.2 Philips Medical Systems Pipeline Products by Development Stage
16.9.3.3 Philips Medical Systems Pipeline Products by Therapy Area
16.9.3.4 Philips Medical Systems Pipeline Products by Clinical Trials
16.9.3.5 Philips Medical Systems Pipeline Products by News Summary
16.10 OSI Systems, Inc.
16.10.1 Company Overview
16.10.2 Value Chain Analysis
16.10.2.1 Manufacturing
16.10.2.2 Product Development
16.10.2.3 Sales and Marketing
16.11 Cardiac Science Corporation
16.11.1 Company Overview
16.11.2 Value Chain Analysis
16.11.2.1 Manufacturing
16.11.2.2 Product Development
16.11.2.3 Sales and Marketing
16.12 Nihon Kohden Corporation
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.2.1 Manufacturing
16.12.2.2 Product Development
16.12.2.3 Sales and Marketing
16.13 Welch Allyn Inc.
16.13.1 Company Overview
16.14 Card Guard AG
16.14.1 Company Overview
16.15 Edwards Lifesciences Corporation
16.15.1 Company Overview
16.15.2 Value Chain Analysis
16.15.2.1 Manufacturing
16.15.2.2 Product Development
16.15.2.3 Sales and Marketing
16.15.3 Edwards Lifesciences Corporation Pipeline Products
16.15.3.1 Edwards Lifesciences Corporation Pipeline Products by Equipment Type
16.15.3.2 Edwards Lifesciences Corporation Pipeline Products by Development Stage
16.15.3.3 Edwards Lifesciences Corporation Pipeline Products by Therapy Area
16.15.3.4 Edwards Lifesciences Corporation Pipeline Products by Clinical Trials
16.15.3.5 Edwards Lifesciences Corporation Pipeline Products by News Summary
16.16 Thoratec Corporation
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.16.2.1 Manufacturing
16.16.2.2 Product Development
16.16.2.3 Sales and Marketing
16.16.3 Thoratec Corporation Pipeline Products
16.16.3.1 Thoratec Corporation Pipeline Products by Equipment Type
16.16.3.2 Thoratec Corporation Pipeline Products by Development Stage
16.16.3.3 Thoratec Corporation Pipeline Products by Therapy Area
16.16.3.4 Thoratec Corporation Pipeline Products by Clinical Trials
16.16.3.5 Thoratec Corporation Pipeline Products by News Summary
16.17 Datascope Corporation
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.2.1 Manufacturing
16.17.2.2 Product Development
16.17.2.3 Sales and Marketing
16.18 Arrow International, Inc.
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.2.1 Manufacturing
16.18.2.2 Product Development
16.18.2.3 Sales and Marketing
16.18.3 Arrow International, Inc. Pipeline Products
16.18.3.1 Arrow International, Inc. Pipeline Products by Equipment Type
16.18.3.2 Arrow International, Inc. Pipeline Products by Development Stage
16.18.3.3 Arrow International, Inc. Pipeline Products by Therapy Area
16.18.3.4 Arrow International, Inc. Pipeline Products by Clinical Trials
16.19 ABIOMED, Inc.
16.19.1 Company Overview
16.19.2 Value Chain Analysis
16.19.2.1 Manufacturing
16.19.2.2 Product Development
16.19.2.3 Sales and Marketing
16.19.3 ABIOMED, Inc. Pipeline Products
16.19.3.1 ABIOMED, Inc. Pipeline Products by Equipment Type
16.19.3.2 ABIOMED, Inc. Pipeline Products by Development Stage
16.19.3.3 ABIOMED, Inc. Pipeline Products by Therapy Area
16.19.3.4 ABIOMED, Inc. Pipeline Products by Clinical Trials
16.19.3.5 ABIOMED, Inc. Pipeline Products by News Summary
16.20 MAQUET GmbH & Co. KG
16.20.1 Company Overview
16.21 AtriCure, Inc.
16.21.1 Company Overview
16.21.2 AtriCure, Inc. Pipeline Products
16.21.2.1 AtriCure, Inc. Pipeline Products by Equipment Type
16.21.2.2 AtriCure, Inc. Pipeline Products by Development Stage
16.21.2.3 AtriCure, Inc. Pipeline Products by Therapy Area
16.21.2.4 AtriCure, Inc. Pipeline Products by Clinical Trials
16.21.2.5 AtriCure, Inc. Pipeline Products by News Summary
16.22 Terumo Corporation
16.22.1 Company Overview
16.22.2 Value Chain Analysis
16.22.2.1 Manufacturing
16.22.2.2 Product Development
16.22.2.3 Sales and Marketing
16.22.3 Terumo Corporation Pipeline Products
16.22.3.1 Terumo Corporation Pipeline Products by Equipment Type
16.22.3.2 Terumo Corporation Pipeline Products by Development Stage
16.22.3.3 Terumo Corporation Pipeline Products by Therapy Area
16.22.3.4 Terumo Corporation Pipeline Products by Clinical Trials
16.22.3.5 Terumo Corporation Pipeline Products by News Summary
16.23 Biosense Webster, Inc.
16.23.1 Company Overview
16.24 CryoCath Technologies Inc.
16.24.1 Company Overview
16.24.2 CryoCath Technologies Inc. Pipeline Products
16.24.2.1 CryoCath Technologies Inc. Pipeline Products by Equipment Type
16.24.2.2 CryoCath Technologies Inc. Pipeline Products by Development Stage
16.24.2.3 CryoCath Technologies Inc. Pipeline Products by Therapy Area
16.24.2.4 CryoCath Technologies Inc. Pipeline Products by Clinical Trials
16.24.2.5 CryoCath Technologies Inc. Pipeline Products by News Summary
16.25 Siemens Healthcare
16.25.1 Company Overview
16.25.2 Value Chain Analysis
16.25.2.1 Manufacturing
16.25.2.2 Product Development
16.25.2.3 Sales and Marketing
16.26 C.R. Bard, Inc.
16.26.1 Company Overview
16.26.2 Value Chain Analysis
16.26.2.1 Manufacturing
16.26.2.2 Product Development
16.26.2.3 Sales and Marketing
16.26.3 C.R. Bard, Inc. Pipeline Products
16.26.3.1 C.R. Bard, Inc. Pipeline Products by Equipment Type
16.26.3.2 C.R. Bard, Inc. Pipeline Products by Development Stage
16.26.3.3 C.R. Bard, Inc. Pipeline Products by Therapy Area
16.26.3.4 C.R. Bard, Inc. Pipeline Products by Clinical Trials
16.27 Invatec S.r.l.
16.27.1 Company Overview
16.27.2 Invatec S.r.l. Pipeline Products
16.27.2.1 Invatec S.r.l. Pipeline Products by Equipment Type
16.27.2.2 Invatec S.r.l. Pipeline Products by Development Stage
16.27.2.3 Invatec S.r.l. Pipeline Products by Therapy Area
16.27.2.4 Invatec S.r.l. Pipeline Products by Clinical Trials
16.27.2.5 Invatec S.r.l. Pipeline Products by News Summary
16.28 ev3 Inc.
16.28.1 Company Overview
16.28.2 Value Chain Analysis
16.28.2.1 Manufacturing
16.28.2.2 Product Development
16.28.2.3 Sales and Marketing
16.28.3 ev3 Inc. Pipeline Products
16.28.3.1 ev3 Inc. Pipeline Products by Equipment Type
16.28.3.2 ev3 Inc. Pipeline Products by Development Stage
16.28.3.3 ev3 Inc. Pipeline Products by Therapy Area
16.28.3.4 ev3 Inc. Pipeline Products by Clinical Trials
16.28.3.5 ev3 Inc. Pipeline Products by News Summary
16.29 DISA Vascular(Pty)Ltd.
16.29.1 Company Overview
16.29.2 DISA Vascular(Pty)Ltd. Pipeline Products
16.29.2.1 DISA Vascular(Pty)Ltd. Pipeline Products By Equipment Type
16.29.2.2 DISA Vascular(Pty)Ltd. Pipeline Products By Development Stage
16.29.2.3 DISA Vascular(Pty)Ltd. Pipeline Products By Therapy Area
16.29.2.4 DISA Vascular(Pty)Ltd. Pipeline Products By Clinical Trials
16.29.2.5 DISA Vascular(Pty)Ltd. Pipeline Products By News Summary
17 Appendix
17.1 Global Markets Direct Research Methodology
17.2 Coverage
17.3 Secondary Research
17.4 Primary Research
17.5 Models
17.6 Forecasts
17.7 Expert Panel Validation
17.8 Currency Conversion
17.9 Contact Us
17.10 Disclaimer



Executive Summary

1.1 List of Tables
Table 1: Healthcare Statistics, South Africa, 2000-2008 32
Table 2: Healthcare Expenditure, South Africa, 2000-2008 32
Table 3: South Africa Trade Statistics, 2004-2008 33
Table 4: Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 40
Table 5: Cardiovascular Devices, South Africa, Overall Revenue ($ mn), 2000-2015 41
Table 6: Cardiovascular Devices, South Africa, Cross-Category Analysis, 2000-2015 42
Table 7: Cardiovascular Devices, South Africa, Overall Revenue ($ mn), Historic, 2000-2008 44
Table 8: Cardiovascular Devices, South Africa, Overall Revenue ($ mn), Forecast, 2008-2015 46
Table 9: Cardiovascular Devices, South Africa, Category Volume (Units), 2000-2015 47
Table 10: Cardiovascular Devices, South Africa, Category Volume (Units), Historic, 2000-2008 49
Table 11: Cardiovascular Devices, South Africa, Category Volume (Units), Forecast, 2008-2015 51
Table 12: Cardiovascular Devices, South Africa, Company Share by Revenue ($ mn), 2007-2008 52
Table 13: Cardiac Rhythm Management, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 53
Table 14: Cardiac Rhythm Management, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 54
Table 15: Cardiac Resynchronisation Therapy, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 55
Table 16: Cardiac Resynchronisation Therapy, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 56
Table 17: Implantable Cardioverter Defibrillator, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 57
Table 18: Implantable Cardioverter Defibrillator, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 58
Table 19: Pacemaker, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 59
Table 20: Pacemaker, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 60
Table 21: Cardiac Rhythm Management, South Africa, Volume (Units) by Segment, Historic, 2000-2008 61
Table 22: Cardiac Rhythm Management, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 62
Table 23: Cardiac Resynchronisation Therapy, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 63
Table 24: Cardiac Resynchronisation Therapy, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 64
Table 25: Implantable Cardioverter Defibrillator, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 65
Table 26: Implantable Cardioverter Defibrillator, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 66
Table 27: Pacemaker, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 67
Table 28: Pacemaker, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 68
Table 29: Cardiac Rhythm Management, South Africa, Average Price ($), Historic, 2000-2008 69
Table 30: Cardiac Rhythm Management, South Africa, Average Price ($), Forecast, 2008-2015 69
Table 31: Cardiac Rhythm Management, South Africa, Distribution Share by Revenue ($mn), 2007-2008 70
Table 32: Cardiac Rhythm Management, South Africa, Company Share by Revenue ($ mn), 2007-2008 71
Table 33: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 73
Table 34: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 74
Table 35: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Volume (Units) by Segment, Historic, 2000-2008 75
Table 36: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 76
Table 37: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Average Price ($), Historic, 2000-2008 77
Table 38: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Average Price ($), Forecast, 2008-2015 77
Table 39: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Distribution Share by Revenue ($mn), 2007-2008 78
Table 40: Cardiovascular Monitoring and Diagnostic Devices, South Africa, Company Share by Revenue ($ mn), 2007-2008 79
Table 41: Cardiovascular Prosthetic Devices, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 80
Table 42: Cardiovascular Prosthetic Devices, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 81
Table 43: Cardiac Assist Devices, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 82
Table 44: Cardiac Assist Devices, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 83
Table 45: Prosthetic Heart Valve, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 84
Table 46: Prosthetic Heart Valve, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 85
Table 47: Cardiovascular Prosthetic Devices, South Africa, Volume (Units) by Segment, Historic, 2000-2008 86
Table 48: Cardiovascular Prosthetic Devices, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 87
Table 49: Cardiac Assist Devices, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 88
Table 50: Cardiac Assist Devices, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 89
Table 51: Prosthetic Heart Valve, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 90
Table 52: Prosthetic Heart Valve, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 91
Table 53: Cardiovascular Prosthetic Devices, South Africa, Average Price ($), Historic, 2000-2008 92
Table 54: Cardiovascular Prosthetic Devices, South Africa, Average Price ($), Forecast, 2008-2015 92
Table 55: Cardiovascular Prosthetic Devices, South Africa, Distribution Share by Revenue ($mn), 2007-2008 93
Table 56: Cardiovascular Prosthetic Devices, South Africa, Company Share by Revenue ($ mn), 2007-2008 94
Table 57: Cardiovascular Surgery, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 95
Table 58: Cardiovascular Surgery, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 96
Table 59: Perfusion Disposables, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 97
Table 60: Perfusion Disposables, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 98
Table 61: Cardiovascular Surgery, South Africa, Volume (Units) by Segment, Historic, 2000-2008 99
Table 62: Cardiovascular Surgery, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 99
Table 63: Perfusion Disposables, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 100
Table 64: Perfusion Disposables, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 101
Table 65: Cardiovascular Surgery, South Africa, Average Price ($), Historic, 2000-2008 102
Table 66: Cardiovascular Surgery, South Africa, Average Price ($), Forecast, 2008-2015 102
Table 67: Cardiovascular Surgery, South Africa, Distribution Share by Revenue ($mn), 2007-2008 103
Table 68: Cardiovascular Surgery, South Africa, Company Share by Revenue ($ mn), 2007-2008 104
Table 69: Electrophysiology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 105
Table 70: Electrophysiology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 106
Table 71: Electrophysiology, South Africa, Volume (Units) by Segment, Historic, 2000-2008 107
Table 72: Electrophysiology, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 107
Table 73: Electrophysiology, South Africa, Average Price ($), Historic, 2000-2008 108
Table 74: Electrophysiology, South Africa, Average Price ($), Forecast, 2008-2015 108
Table 75: Electrophysiology, South Africa, Distribution Share by Revenue ($mn), 2007-2008 109
Table 76: Electrophysiology, South Africa, Company Share by Revenue ($ mn), 2007-2008 110
Table 77: Interventional Cardiology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 112
Table 78: Interventional Cardiology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 113
Table 79: Cardiac Catheter, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 114
Table 80: Cardiac Catheter, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 115
Table 81: Coronary Stent, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 116
Table 82: Coronary Stent, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 117
Table 83: PTCA Balloon, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 118
Table 84: PTCA Balloon, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 119
Table 85: Interventional Cardiology, South Africa, Volume (Units) by Segment, Historic, 2000-2008 120
Table 86: Interventional Cardiology, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 121
Table 87: Cardiac Catheter, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 122
Table 88: Cardiac Catheter, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 123
Table 89: Coronary Stent, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 124
Table 90: Coronary Stent, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 125
Table 91: PTCA Balloon, South Africa, Volume (Units) by Sub-Segment, Historic, 2000-2008 126
Table 92: PTCA Balloon, South Africa, Volume (Units) by Sub-Segment, Forecast, 2008-2015 127
Table 93: Interventional Cardiology, South Africa, Average Price ($), Historic, 2000-2008 128
Table 94: Interventional Cardiology, South Africa, Average Price ($), Forecast, 2008-2015 129
Table 95: Interventional Cardiology, South Africa, Distribution Share by Revenue ($mn), 2007-2008 130
Table 96: Interventional Cardiology, South Africa, Company Share by Revenue ($ mn), 2007-2008 131
Table 97: Peripheral Vascular Devices, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 133
Table 98: Peripheral Vascular Devices, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 135
Table 99: Peripheral Vascular Devices, South Africa, Volume (Units) by Segment, Historic, 2000-2008 137
Table 100: Peripheral Vascular Devices, South Africa, Volume (Units) by Segment, Forecast, 2008-2015 139
Table 101: Peripheral Vascular Devices, South Africa, Average Price ($), Historic, 2000-2008 140
Table 102: Peripheral Vascular Devices, South Africa, Average Price ($), Forecast, 2008-2015 140
Table 103: Peripheral Vascular Devices, South Africa, Distribution Share by Revenue ($mn), 2007-2008 141
Table 104: Peripheral Vascular Devices, South Africa, Company Share by Revenue ($ mn), 2007-2008 142
Table 105: Boston Scientific Corporation Pipeline Products by Equipment Type 147
Table 106: Boston Scientific Corporation Pipeline Products by Development Stage 148
Table 107: Boston Scientific Corporation Pipeline Products by Therapy Area 149
Table 108: Boston Scientific Corporation Pipeline Products by Clinical Trials 150
Table 109: Boston Scientific Corporation Pipeline Products by News Summaries 151
Table 110: Medtronic, Inc. Pipeline Products by Equipment Type 155
Table 111: Medtronic, Inc. Pipeline Products by Development Stage 157
Table 112: Medtronic, Inc. Pipeline Products by Therapy Area 159
Table 113: Medtronic, Inc. Pipeline Products by Clinical Trials 161
Table 114: Medtronic, Inc. Pipeline Products by News Summaries 162
Table 115: Cordis Corporation Pipeline Products by Equipment Type 163
Table 116: Cordis Corporation Pipeline Products by Development Stage 163
Table 117: Cordis Corporation Pipeline Products by Therapy Area 164
Table 118: Cordis Corporation Pipeline Products by Clinical Trials 164
Table 119: Cordis Corporation Pipeline Products by News Summaries 164
Table 120: St. Jude Medical Inc. Pipeline Products by Equipment Type 172
Table 121: St. Jude Medical Inc. Pipeline Products by Development Stage 172
Table 122: St. Jude Medical Inc. Pipeline Products by Therapy Area 173
Table 123: St. Jude Medical Inc. Pipeline Products by Clinical Trials 173
Table 124: St. Jude Medical Inc. Pipeline Products by News Summaries 174
Table 125: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 175
Table 126: BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage 175
Table 127: BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area 176
Table 128: BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials 176
Table 129: BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary 176
Table 130: Sorin Group Pipeline Products by Equipment Type 181
Table 131: Sorin Group Pipeline Products by Development Stage 182
Table 132: Sorin Group Pipeline Products by Therapy Area 182
Table 133: Sorin Group Pipeline Products by Clinical Trials 183
Table 134: Sorin Group Pipeline Products by News Summary 183
Table 135: Philips Medical Systems Pipeline Products by Equipment Type 187
Table 136: Philips Medical Systems Pipeline Products by Development Stage 187
Table 137: Philips Medical Systems Pipeline Products by Therapy Area 188
Table 138: Philips Medical Systems Pipeline Products by Clinical Trials 188
Table 139: Philips Medical Systems Pipeline Products by News Summary 188
Table 140: Edwards Lifesciences Corporation Pipeline Products by Equipment Type 201
Table 141: Edwards Lifesciences Corporation Pipeline Products by Development Stage 202
Table 142: Edwards Lifesciences Corporation Pipeline Products by Therapy Area 202
Table 143: Edwards Lifesciences Corporation Pipeline Products by Clinical Trials 203
Table 144: Edwards Lifesciences Corporation Pipeline Products by News Summary 203
Table 145: Thoratec Corporation Pipeline Products by Equipment Type 207
Table 146: Thoratec Corporation Pipeline Products by Development Stage 207
Table 147: Thoratec Corporation Pipeline Products by Therapy Area 207
Table 148: Thoratec Corporation Pipeline Products by Clinical Trials 208
Table 149: Thoratec Corporation Pipeline Products by News Summary 208
Table 150: Arrow International, Inc. Pipeline Products by Equipment Type 215
Table 151: Arrow International, Inc. Pipeline Products by Development Stage 215
Table 152: Arrow International, Inc. Pipeline Products by Therapy Area 215
Table 153: Arrow International, Inc. Pipeline Products by Clinical Trials 215
Table 154: ABIOMED, Inc. Pipeline Products by Equipment Type 219
Table 155: ABIOMED, Inc. Pipeline Products by Development Stage 219
Table 156: ABIOMED, Inc. Pipeline Products by Therapy Area 219
Table 157: ABIOMED, Inc. Pipeline Products by Clinical Trials 220
Table 158: ABIOMED, Inc. Pipeline Products by News Summary 220
Table 159: AtriCure, Inc. Pipeline Products by Equipment Type 221
Table 160: AtriCure, Inc. Pipeline Products by Development Stage 221
Table 161: AtriCure, Inc. Pipeline Products by Therapy Area 222
Table 162: AtriCure, Inc. Pipeline Products by Clinical Trials 222
Table 163: AtriCure, Inc. Pipeline Products by News Summary 222
Table 164: Terumo Corporation Pipeline Products by Equipment Type 225
Table 165: Terumo Corporation Pipeline Products by Development Stage 225
Table 166: Terumo Corporation Pipeline Products by Therapy Area 225
Table 167: Terumo Corporation Pipeline Products by Clinical Trials 226
Table 168: Terumo Corporation Pipeline Products by News Summaries 226
Table 169: CryoCath Technologies Inc. Pipeline Products by Equipment Type 228
Table 170: CryoCath Technologies Inc. Pipeline Products by Development Stage 228
Table 171: CryoCath Technologies Inc. Pipeline Products by Therapy Area 228
Table 172: CryoCath Technologies Inc. Pipeline Products by Clinical Trials 229
Table 173: CryoCath Technologies Inc. Pipeline Products by News Summary 229
Table 174: C.R. Bard, Inc. Pipeline Products by Equipment Type 235
Table 175: C.R. Bard, Inc. Pipeline Products by Development Stage 236
Table 176: C.R. Bard, Inc. Pipeline Products by Therapy Area 236
Table 177: C.R. Bard, Inc. Pipeline Products by Clinical Trials 237
Table 178: Invatec S.r.l. Pipeline Products by Equipment Type 238
Table 179: Invatec S.r.l. Pipeline Products by Development Stage 239
Table 180: Invatec S.r.l. Pipeline Products by Therapy Area 240
Table 181: Invatec S.r.l. Pipeline Products by Clinical Trials 241
Table 182: Invatec S.r.l. Pipeline Products by News Summary 241
Table 183: ev3 Inc. Pipeline Products by Equipment Type 245
Table 184: ev3 Inc. Pipeline Products by Development Stage 245
Table 185: ev3 Inc. Pipeline Products by Therapy Area 246
Table 186: ev3 Inc. Pipeline Products by Clinical Trials 246
Table 187: ev3 Inc. Pipeline Products by News Summary 246
Table 188: DISA Vascular(Pty)Ltd. Pipeline Products by Equipment Type 247
Table 189: DISA Vascular(Pty)Ltd. Pipeline Products By Development Stage 247
Table 190: DISA Vascular(Pty)Ltd. Pipeline Products By Therapy Area 248
Table 191: DISA Vascular(Pty)Ltd. Pipeline Products By Clinical Trials 248
Table 192: DISA Vascular(Pty)Ltd. Pipeline Products By News Summary 248
Table 193: USD to Local Currency, Average Exchange Rate 2008 253



Companies Mentioned Boston Scientific Corporation Medtronic, Inc. Cordis Corporation Abbott Laboratories St. Jude Medical Inc. BIOTRONIK GmbH & Co. KG Sorin S.p.A. GE Healthcare Philips Healthcare OSI Systems, Inc. Cardiac Science Corporation Nihon Kohden Corporation Welch Allyn Inc. Card Guard AG Edwards Lifesciences Corporation Thoratec Corporation Datascope Corporation Arrow International, Inc. ABIOMED, Inc. MAQUET GmbH & Co. KG AtriCure, Inc. Terumo Corporation Biosense Webster, Inc. CryoCath Technologies Inc. Siemens Healthcare C.R. Bard, Inc. Invatec S.r.l. ev3 Inc. DISA Vascular(Pty)Ltd.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1053525

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 09:27:55
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
South Africa Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Web Address:
http://www.researchandmarkets.com/reports/1053525

Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,679.00
Electronic (PDF) - Site License €3,358.00
Electronic (PDF) - Enterprisewide €5,037.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 09:27:55


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)